000			02957cam a22004097i 4500
005			20250919090011.0
008			170213t20142014nyua bi 001 0 eng d
020			_a9781633216662 _cRM668.80
020			_a1633216667
039		9	_a201706081555 _bfida _c201705301451 _dfida _y02-13-2017 _zruzini
040			_aYDXCP _beng _cYDXCP _erda _dBTCTA _dOCLCO _dOCLCF _dOCLCO _dOCLCQ _dIHI _dOCLCO _dDLC _dUKM _erda
090			_aWJ504.B632 2014 9
090			_aWJ504 _b.B632 2014 9
245	0	0	_aBladder cancer : _brisk factors, emerging treatment strategies and challenges / _cSamantha Haggerty, editor.
264		1	_aNew York : _bNova Biomedical, _c2014.
264		4	_c©2014.
300			_a174 pages : _billustrations (some color) ; _c23 cm.
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
490	1		_aCancer etiology, diagnosis and treatments.
504			_aIncludes bibliographical references and index.
505	0	0	_tCancer stem cell (CSC) in bladder malignancy / _rJianmin Zhang _g(and two others) -- _tThe five senses in bladder cancer diagnostics / _rCaterina Gulia _g(and four others) -- _tBladder cancer in pediatric patients / _rSantiago Vallasciani _g(and four others) -- _tMulti-tasking chemoinformatic model for the efficient discovery of potent and safer anti-bladder cancer agents / _rAlejandro Speck-Planche and M. N. D. S. Cordeiro -- _tLong non coding mitochondrial RNAs as potential targets for diagnosis and therapy of bladder cancer / _rJamie Villegas _g(and ten others) -- _tHistological variants of urothelial carcinoma / _rHyung Suk Kin and Ja Hyeon Ku -- _tNovel therapeutic modalities in patients with advanced or metastatic urothelial carcinoma / _rKazumasa Matsumoto _g(and four others).
520			_aBladder cancer is the fifth most common form of cancer worldwide and is mainly prevalent in developed countries. It is thought to arise through two distinct pathways: the noninvasive and the invasive. The noninvasive pathway gives rise to a superficial papillary carcinoma that is characterized by activating mutations in oncogenes such as H-ras, FGFR3 and PI3K. This pathway is rarely lethal as superficial papillary carcinomas can be readily removed through transurethral resection. However, 15% of noninvasive urothelial tumors can transform into invasive carcinomas and have high recurrence 80%.-- _cSource other than Library of Congress.
650		2	_aUrinary Bladder Neoplasms.
700	1		_aHaggerty, Samantha, _eeditor.
710	2		_aNova Biomedical (Publishing company).
830		0	_aCancer etiology, diagnosis, and treatments.
907			_a.b16427853 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kWJ504.B632 2014 9
914			_avtls003616987
990			_afn
991			_aProgram Sains Bioperubatan, FSK, KKL
998			_ad _b2017-01-02 _cm _da _feng _gnyu _y0 _z.b16427853
999			_c616034 _d616034